Stakeholders Tout Virtual Reality Devices As FDA Struggles With Oversight

Stakeholders touted virtual reality and augmented reality health devices for their potential to improve health inequities and health care, as FDA officials struggled with how to regulate the safety and privacy of the technology during the first day of a two-day meeting of the FDA’s Patient Engagement Advisory Committee (PEAC) Tuesday (July 12). Jeff Shuren, director of the Center for Devices and Radiological Health, said the FDA has authorized several devices that use AR/VR for a variety of health applications...